ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Review Of Cancer Center supports Grants Needs Refocus On Science, Advisors Say

October 18, 1996

FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.

June 9, 2006

Rosenberg’s Gene Transfer Protocol Approved By NIH Advisory Group

October 7, 1988

Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015.

November 23, 2005

NCI Budget Chief John Hartinger Retires.

August 4, 2006